ClinicalTrials.gg
CompletedNCT01231243Updated Dec 6, 2011

Clinical Effectiveness of In-office Bleaching Activated With a LED/Laser Device

A Phase 4 interventional study of in-office bleaching with/without light in Tooth Discoloration, sponsored by Universidade Estadual de Ponta Grossa. Completed at 1 site in Brazil. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-12-06.

Sponsored by Universidade Estadual de Ponta Grossa · Phase 4, Interventional, and Supportive care

Phase
Phase 4
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

There is a controversy in the dentistry literature about how the use of associated light to activate 35% hydrogen peroxide gel during in-office tooth bleaching may increase the bleaching effectiveness. The studies that demonstrated an increased level of bleaching using light activation employed lower hydrogen peroxide gels while the ones reporting no statistical difference employed higher hydrogen peroxide gels.

The hypothesis of this study is that the effectiveness of light activation tooth bleaching in dependent on the hydrogen peroxide concentration employed.

Read the detailed description

The aim of this study is to compare the color change and tooth sensitivity of in-office bleaching using different hydrogen peroxide concentrations and with or without light activation. Sixty patients will be enrolled in this trial and divide equally into 4 groups according to the combination of the main factors hydrogen peroxide concentration (35% or 20%) or LED/laser activation (yes or no). Three 15-min applications will be performed in each clinical appointment. A LED/laser device will be used in the respective groups for three 1-min application with an interval of 2 min. The same procedure will be repeated one week later. The color change will be assessed after hte 1st and 2nd session, after 1 week and 6 months of the end of the treatment using a value-oriented shade Vita Classical and a spectrophotometer Easy Shade. The tooth sensitivity will be reported by patients using a 0 to 10 visual analog scale. The Student t test (α = .05) will be used to compare the tooth color changes and the intensity of tooth sensitivity between groups at baseline and immediately after the first and second bleaching appointments. The Fisher exact test and Student t test (α = .05), respectively, will be used to analyze the percentage of patients with tooth sensitivity and its intensity.

02

Conditions studied

  • Tooth Discoloration

Browse trials for

Keywords

  • tooth bleaching, bleaching agent, hydrogen peroxide
03

In context

Tooth Discoloration

105 studies on the registry are indexed under Tooth Discoloration; 19 are open to participants now.

This study's enrollment of 60 is above the median of 48 across 97 interventional studies indexed under Tooth Discoloration.

Browse Tooth Discoloration studies →

Lead sponsor

Universidade Estadual de Ponta Grossa is the lead sponsor of 8 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants should be at least 18 years old;
  • Participants should have good general and oral health
  • Participants should have six caries-free maxillary anterior teeth without restorations on the labial surfaces
  • Participants should be willing to sign a consent form
  • Participants should have central incisors darker than shade C2.

Exclusion criteria

Exclusion Criteria:

  • Participants that had undergone tooth-whitening procedures
  • Participants that had labial anterior restorations, were pregnant or lactating.
  • Participants with severe internal tooth discoloration (such as tetracycline stains, fluorosis, pulpless teeth).
  • Participants with bruxism habits or any gross pathology in the mouth
05

Study design

Phase
Phase 4
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    35% hydrogen peroxide control

    The tooth bleaching will be performed using a high hydrogen peroxide concentration (35%) without light-activation with LED/light device

    Procedure: in-office bleaching with/without light

  • Active comparator
    20% hydrogen peroxide

    The tooth bleaching will be performed with a low hydrogen peroxide concentration (20%) without light activation with a LED/laser device

    Procedure: in-office bleaching with/without light

  • Experimental
    35% hydrogen peroxide + light

    The tooth bleaching will be performed with a high hydrogen peroxide concentration (35%) associated with LED/laser light activation

    Procedure: in-office bleaching with/without light

  • Experimental
    20% hydrogen peroxide + light

    The tooth bleaching will be performed with a low hydrogen peroxide concentration (20%) associated with LED/laser light activation

    Procedure: in-office bleaching with/without light

Interventions

  • Procedurein-office bleaching with/without light

    Two clinical sessions of tooth bleaching will be performed in each patient with a 1-week interval between them. In each session, three 15-min applications of the gel will be done using one of the two concentrations under investigation. In half of the sample of each concentration, the gel will be activated with a LED/laser device for a total of 3 min, as specified by the DMC manufacturer.

    Also known as: Tooth bleaching, Hydrogen peroxide, In-office bleaching, Light activation, Hydrogen peroxide concentration

06

What researchers measure

Primary outcomes

  1. Change in color

    The change in color will be measured using Vita Shade Classical scale at baseline and after the end of the bleaching protocol. A spectrophootometer Easy Shade will also be used and the coordinates of the CIELab system will be recorded.

    Time frame: at the 2-week recall

Secondary outcomes

  1. Prevalence and intensity of tooth sensitivity

    The visual analog scale will be used for patients to record their tooth sensitivity in a 0 to 10 scale.

    Time frame: 24-hours after the bleaching

07

Study locations

1 site
  • School of Dentistry - Universidade Estadual de Ponta Grossa
    Ponta Grossa, Paraná 84030-900, Brazil
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2011, a primary completion of Sep 2011 and a completion of Sep 2011. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 28, 2010
First posted
Nov 1, 2010
Start
Jan 2011
Primary completionActual
Sep 2011
CompletionActual
Sep 2011
Last update
Dec 6, 2011
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 6, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01231243
Lead sponsor
Universidade Estadual de Ponta Grossa
Responsible party
Alessandra Reis (PhD, Universidade Estadual de Ponta Grossa) — Principal investigator
First posted
Nov 1, 2010
Start date
Jan 2011
Primary completion
Sep 2011
Completion
Sep 2011
Last update
Dec 6, 2011

Study contacts

Alessandra Reis, DDS, MS
principal investigator · Universidade Estadual de Ponta Grossa

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion